Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 3:07 PM ISTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...